skip nav
National Prevention Information Network
Search Help
Other Searches: Search Organizations | Search Materials | Search Campaign Resources | Search Funding
español
Share Share this page on Twitter Share this page on Facebook Share this page on LinkedIn View more options to share this page E-mail this page to a colleague Print this page


<< Back

Funding

Advancing Exceptional Research on HIV/AIDS (R01)

Description
Grant Amount: NIDA intends to commit $2M in FY 2014 to fund 2-3 awards.

This FOA will support highly innovative R01 applications on HIV/AIDS and drug abuse and will complement the Avant-Garde Award Program for HIV/AIDS research. The Avant-Garde award http://ww2.drugabuse.gov/about/organization/arp/AVGP.htm supports individuals who conduct high-risk, high-payoff research and does not require a detailed research plan. Applications submitted under this FOA are required to have a detailed research plan and preliminary data. This FOA focuses on innovative research projects that have the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention and treatment of HIV/AIDS among substance abusers. The nexus with substance abuse should be clearly described. This FOA is open to both individual researchers and research teams and is not limited to any one area of research.

This FOA seeks to attract exceptionally talented investigators to conduct innovative, potentially groundbreaking and/or unconventional investigations on HIV/AIDS and substance abuse. Projects may be led by collaborative investigative teams or individual scientists. Awards will support projects, which, if successful, will have a major impact on HIV/AIDS and substance abuse. Examples of studies of relevance to drug abuse would include: studies using populations with significant numbers of drug users or samples from drug using populations; studies using in vitro systems and/or animal models that test the effects of drugs of abuse on HIV pathogenesis, progression, or treatment; and studies to develop interventions or treatments that are tailored to substance using populations. Projects may be in any area of research but must be in an area described in the Trans – NIH Plan for HIV-Related Researchhttp://www.oar.nih.gov/strategicplan/. While not limited to any one area of research, this award is well suited to conducting translational studies. However, studies are not required to include a translational element. This FOA is designed to complement NIDA's existing Avant-Garde Award Program for HIV/AIDS Research, which focuses on individual researchers and which does not require a detailed research plan. In contrast, this FOA focuses on innovative research projects, and applications to this FOA are required to have a detailed research plan and preliminary data. Applications submitted under this FOA should clearly exhibit creativity, innovativeness, and risk.

Funding Organization
National Institute on Drug Abuse
Fund Category
HIV/AIDS
Support Types
Awards/Prizes/Competitions
Research
Locations
International
National
Eligible Organizations
City Agencies
Colleges/Universities
Commercial Organizations
Community Based Organizations
County Agencies
Educational Organizations/Institutions
Federal Government Agencies
International Agencies
IRS 501 (c)(3) Organizations
Nonprofit Organizations
Religious Organizations
Schools
State Agencies
Tribal Organizations
Number of Awards Given
2 to 3 awards
Award Amount Notes
NIDA intends to commit $2M in FY 2014 to fund 2-3 awards.
Letter of Intent Date
7/1/2013
Application Due Date
8/1/2013
Project Start Date
4/1/2014
Application Contact
GrantsInfo
,
Phone: (301) 435-0714
Technical Contact
Jacques Normand
Director
AIDS Research ProgramNIDA

Phone: (301) 402-1919
Fund Duration
Up to 5 years.
Subjects
Drug Abuse
HIV/AIDS Prevention
Medical Treatments and Therapies
Research Programs
Audiences
Researchers
Application Process
Applicants must download the SF424 (R&R) application package associated with this funding opportunity using the “Apply for Grant Electronically” button in this FOA or following the directions provided at Grants.gov.

It is critical that applicants follow the instructions in the SF424 (R&R) Application Guide (http://grants.nih.gov/grants/funding/424/SF424_RR_Guide_General_Adobe_VerB.pdf), except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.

Web Site
http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-14-003.html
Fund Number
RFA-DA-14-003

Disclaimer: NPIN provides this information as a public service only. The views and information provided about the materials, funding opportunities, and organizations do not necessarily state or reflect those of the U.S. Department of Health and Human Services, CDC, or NPIN.

cdcnpin.org Fund Record #4684

<< Back

CDCNPIN.org

Contact Us
About Us
HIV Content Notice
Privacy Policy
Policies & Disclaimers
Site Index
Help Using the CDC NPIN Web Site

CDC NPIN Searches

Search Organizations
Search Materials
Search Funding Opportunities
Search Campaign Resources
Help Using the CDC NPIN Searches

CDC NPIN Resources

hivtest.cdc.gov
m.hivtest.cdc.gov
findtbresources.org
STD Awareness Microsite
findstdtest.org
AIDS Gov Logo and Link CDC Logo and Link